LD-2 disclosure · 1st Quarter - Report
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Client
- Name
- BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
- Location
- District of Columbia · United States of America
Registrant
- Firm
- BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
- Description
- Charitable funder of diabetes research
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
2 issuesBudget/Appropriations
Issues related to funding for the National Institutes of Health and the U.S. Food and Drug Administration
LobbyistsLAURA WHITTON · NIELS KNUTSON · PEDRO MONTENEGRO · CHRISTINA INGRAM
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Issues related to prescription drug pricing, particularly as it relates to insulin S. 146 - Cap Insulin Prices Act HR 1488/S. 954 - Affordable Insulin Now Act H.R. 1485 - Insulin for All Act of 2023 H.R.1587 - Making Insulin Affordable for All Children Act Issues related to the Special Diabetes Program renewal
LobbyistsLAURA WHITTON · NIELS KNUTSON · PEDRO MONTENEGRO · CHRISTINA INGRAM
TargetedSENATE · HOUSE OF REPRESENTATIVES
